{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T04:07:59Z","timestamp":1751947679983,"version":"3.41.2"},"reference-count":0,"publisher":"Sociedad Espanola de Quimioterapia","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev Esp Quimioter"],"published-print":{"date-parts":[[2025,7,7]]},"abstract":"<jats:p>Objetivo: Evaluar c\u00f3mo influy\u00f3 en el consumo de antimicrobianos el aumento de la frecuencia de las reuniones en las que el equipo PROA (Programa de Optimizaci\u00f3n del Uso de Antimicrobianos) realiz\u00f3 auditor\u00edas no impositivas de ayuda a la prescripci\u00f3n. Materiales y m\u00e9todos: Estudio observacional de cohortes retrospectivo en que se compar\u00f3 el consumo en DDD\/1000 estancias y DDD\/1000 ingresos por grupos de antiinfecciosos, grupos antibacterianos, agentes activos frente Staphylococcus aureus sensibles a meticilina (agentes anti-SASM)\/agentes activos frente Staphylococcus aureus resistente a meticilina (agentes anti-SARM), antibi\u00f3ticos frente bacterias gramnegativas sensibles\/antibi\u00f3ticos frente bacterias gramnegativas resistentes y antimicrobiano, en dos per\u00edodos de actividad del PROA (2 reuniones semanales en 2023 versus 1 reuni\u00f3n semanal en 2022). Resultados: En 2023 respecto 2022: el consumo de antibi\u00f3ticos para uso sist\u00e9mico creci\u00f3 en DDD\/1000 estancias (+0,13%) y disminuy\u00f3 en DDD\/1000 ingresos (-3,55%); el consumo en DDD\/1000 estancias y DDD\/1000 ingresos aument\u00f3 para penicilinas, glucop\u00e9ptidos y aminogluc\u00f3sidos y decreci\u00f3 en cefalosporinas y carbapen\u00e9micos, para quinolonas aument\u00f3 por estancias y disminuy\u00f3 por ingresos; en agentes anti-SASM y anti-SARM, el uso de cefazolina, cloxacilina, vancomicina y daptomicina aument\u00f3 por DDD\/1000 estancias y DDD\/1000 ingresos, para linezolid creci\u00f3 por estancias y disminuy\u00f3 por ingresos; en antibi\u00f3ticos frente bacterias gramnegativas sensibles y antibi\u00f3ticos frente bacterias gramnegativas resistentes, aument\u00f3 el consumo de amoxicilina-clavul\u00e1nico, piperacilina-tazobactam, aminogluc\u00f3sidos, ceftazidima, cefepima y polimixinas por DDD\/1000 estancias y DDD\/1000 ingresos, para carbapen\u00e9micos decreci\u00f3 por estancias e ingresos. Conclusiones: El aumento de la frecuencia de las reuniones parece relacionarse con un mejor uso de los antimicrobianos en nuestro centro.<\/jats:p>","DOI":"10.37201\/req\/022.2025","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T14:53:33Z","timestamp":1748357613000},"page":"305-318","source":"Crossref","is-referenced-by-count":0,"title":["Repercusi\u00f3n del aumento de la periodicidad de las reuniones en las que el equipo del Programa de Optimizaci\u00f3n del Uso de Antimicrobianos realiz\u00f3 auditor\u00edas no impositivas de ayuda a la prescripci\u00f3n en el consumo de antimicrobianos"],"prefix":"10.37201","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7026-4744","authenticated-orcid":false,"given":"Mar\u00eda Inmaculada","family":"Zas-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4097-3224","authenticated-orcid":false,"given":"Jos\u00e9 Manuel","family":"Fern\u00e1ndez-Carreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2612-8278","authenticated-orcid":false,"given":"Jorge","family":"Rodr\u00edguez-Prida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3435-7919","authenticated-orcid":false,"given":"Ana","family":"Blanco-Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3783-6158","authenticated-orcid":false,"given":"Marcos","family":"\u00c1lvarez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4554-1866","authenticated-orcid":false,"given":"Jes\u00fas","family":"Rubio-Sanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6775-5750","authenticated-orcid":false,"given":"Elsa","family":"Castelo-\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8252-2948","authenticated-orcid":false,"given":"Daniel","family":"Gonz\u00e1lez-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1702-1071","authenticated-orcid":false,"given":"Tania","family":"Rubio-Alfonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"23328","published-online":{"date-parts":[[2025,5,27]]},"container-title":["Revista Espa\u00f1ola de Quimioterapia"],"original-title":[],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T11:44:51Z","timestamp":1751888691000},"score":1,"resource":{"primary":{"URL":"https:\/\/revespquimioterapia.com\/articulo\/repercusion-del-aumento-de-la-periodicidad-de-las-reuniones-en-las-que-el-equipo-del-programa-de-optimizacion-del-uso-de-antimicrobianos-realizo-auditorias-no-impositivas-de-ayuda-a-la-prescripcion-en-el-consumo-de-antimicrobianos"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,27]]},"references-count":0,"issue-title":["Volume 38, Issue 4"],"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,7,7]]},"published-print":{"date-parts":[[2025,7,7]]}},"URL":"https:\/\/doi.org\/10.37201\/req\/022.2025","relation":{},"ISSN":["1988-9518","0214-3429"],"issn-type":[{"type":"electronic","value":"1988-9518"},{"type":"print","value":"0214-3429"}],"subject":[],"published":{"date-parts":[[2025,5,27]]}}}